🔗 Visit the ClinicalTrials.gov page for NCT01676714
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Molecular pathways and therapeutic targets in lung cancer. | Oncotarget | 2014 | 1.16 |
| 2 | Understanding and targeting resistance to anti-angiogenic therapies. | J Gastrointest Oncol | 2013 | 1.05 |
| 3 | Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor. | Semin Oncol | 2013 | 1.03 |
| 4 | The minority report: targeting the rare oncogenes in NSCLC. | Curr Treat Options Oncol | 2014 | 0.78 |
| 5 | Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors. | Cancer Med | 2014 | 0.78 |